Patrice Wendling
News
The earlier the better for colchicine post-MI: COLCOT
September 14, 2020
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
News
NAFLD may predict arrhythmia recurrence post-AFib ablation
August 14, 2020
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.
![1]()
News
‘Doubling down’ on hydroxychloroquine QT prolongation in COVID-19
August 12, 2020
Patients had progressively longer QT intervals with hydroxychloroquine plus azithromycin, but also frequently received other drugs that had QT-prolonging effects, in a new study.
News
Myocarditis in COVID-19: An elusive cardiac complication
July 8, 2020
“There are some experts who believe we’re likely still dealing with myocarditis but with atypical features, while others suggest there is no myocarditis by strict classic criteria.”
News
FDA okays emergency use for Impella RP in COVID-19 right heart failure
June 2, 2020
The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.
![1]()
News
Evidence builds linking anticoagulation to COVID-19 survival
May 8, 2020
“Any family of mine who will have this disease absolutely will be on antithrombotic therapy and, actually, so are all of the patients at Mount Sinai.” – Valentin Fuster
News
Multisociety roadmap eyes restarting elective cardiac cases
May 6, 2020
A new consensus document provides guidance on the safe reintroduction of cardiovascular procedures and testing derailed by the COVID-19 pandemic.
News
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
May 1, 2020
Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%.
![1]()
News
COVID-19 shifts telehealth to the center of cardiology
March 25, 2020
A series of recent mandates aimed at addressing barriers to telehealth ‘have come in a time of desperation,’ one New York–based cardiologist says.
